SCHEMBL3469334

SCHEMBL3469334

CN(C)C1(N(C)C=O)CCCCC1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167489 0.76 SLC6A2 (0.33)
SCHEMBL28429358 0.73 ADH1C (0.34) ADH1CADH1ATSHR
SCHEMBL25137307 0.73 SLC6A2 (0.30)
Hydrochloric Acid SCHEMBL7213348 0.70
SCHEMBL18923967 0.68 TSHR (0.32) ADH1CADH1ATSHR
SCHEMBL875733 0.65 ADH1C (0.31) ADH1CADH1A
SCHEMBL28656107 0.63
Cyclohexane SCHEMBL1031601 0.63 TSHR (0.75) ADH1CADH1ATSHR
SCHEMBL2089289 0.62
SCHEMBL4118119 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP claimed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO claimed
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP disclosed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO disclosed